<DOC>
	<DOCNO>NCT03020290</DOCNO>
	<brief_summary>Endovascular treatment stenting currently use treatment femoro-popliteal lesion . This technique tend extend lesion gold standard remain open surgery treatment ( lesion TASC C D ) . The primary objective study evaluate clinical efficacy 12 month SuperA stent ( Abbott ) treatment long de novo atherosclerotic lesion TASC C D patient symptomatic peripheral arterial disease . The secondary objective evaluate clinical effectiveness SuperA stent 24 month , accord clinical , morphological haemodynamic criterion , possible influence calcification quality life patient . The SuperA stent treatment specifically provide Protocol carry within framework care . This study observationnal study .</brief_summary>
	<brief_title>Long Superficial Femoral Artery Stenting With SuperA Interwoven Nitinol Stents</brief_title>
	<detailed_description>Patient recruit 1 year . Patient follow study 2 year . Pre-operative exam collect . Patients ask give oral authorization participate study surgeon . Patient include next day intervention . Endovascular treatment femoropopliteal lesion SuperA stents medical care : Intervention achieve operative room , local anesthesia sedation general anesthesia . An angio-CT arteriography necessary attest presence TASC C D lesion involve superficial femoral and/or popliteal artery . The long femoropopliteal lesion must pre-dilated 3 minute balloon 1mm diameter stent implant . A control arteriography do implantation stent end intervention ass success procedure . If need , endovascular treatment could realize inflow outflow time . Patient follow-up : Patient follow-up perform 1 , 6 , 12 24 month . Follow-up systematically include clinical evaluation duplex scan ankle brachial index ( ABI ) . The x-rays quality life questionnaire do 1 , 12 24 month . All clinical surveillance event , complication re-hospitalizations collect .</detailed_description>
	<mesh_term>Atherosclerosis</mesh_term>
	<criteria>Inclusion criterion : Age &gt; 18 year , Symptomatic PAD , Rutherford 2 6 Atherosclerotic femoropopliteal lesion TASC C D ( CT scan arteriography ) De novo femoropopliteal lesion Patient inform study oral authorization collect Underage patient Patient age , legal guardianship care Potentially pregnant woman Patients understand French language Asymptomatic lesion Acute ischemia acute thrombosis Lesion already treat Noatherosclerotic disease hemostasis disorder severe comorbidity life expectancy le 2 year contraindication antiplatelet ( dual antiplatelet therapy require least 2 month postintervention ) patient participate clinical trial likely interfer Comorbidity , accord investigator , may interferer conduct study lesion near aneurysm Patient followup impossible Patient refuse participate</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>femoropopliteal artery</keyword>
	<keyword>interwoven nitinol stent</keyword>
	<keyword>self-expanding-endovascular</keyword>
	<keyword>TASC C TASC D</keyword>
	<keyword>Peripheral Arterial Disease</keyword>
</DOC>